A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Oral treatment with a vitamin D3 analogue (BXL628) has anti-inflammatory effects in rodent model of interstitial cystitis
Tekijät: Benigni F, Baroni E, Zecevic M, Zvara P, Streng T, Hedlund P, Colli E, D'Ambrosio D, Andersson KE
Kustantaja: BLACKWELL PUBLISHING
Julkaisuvuosi: 2006
Lehti:BJU International
Tietokannassa oleva lehden nimiBJU INTERNATIONAL
Lehden akronyymi: BJU INT
Vuosikerta: 97
Numero: 3
Aloitussivu: 617
Lopetussivu: 624
Sivujen määrä: 8
ISSN: 1464-4096
DOI: https://doi.org/10.1111/j.1464-410X.2006.05971.x
Tiivistelmä
Vitamin D3 analogues may successfully be used as anti-inflammatory agents in allergen-mediated inflammatory reactions. Moreover, the modulatory effect shown on mast cell activation by the BXL628 analogue strongly supports its potential therapeutic use in a possibly mast cell-dependent disease such as human interstitial cystitis.
Vitamin D3 analogues may successfully be used as anti-inflammatory agents in allergen-mediated inflammatory reactions. Moreover, the modulatory effect shown on mast cell activation by the BXL628 analogue strongly supports its potential therapeutic use in a possibly mast cell-dependent disease such as human interstitial cystitis.